We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Mersana Therapeutics Presents Positive Data on Next-Gen Antibody-Drug Conjugate Technology

News   Apr 10, 2013

 
Mersana Therapeutics Presents Positive Data on Next-Gen Antibody-Drug Conjugate Technology
 
 
 

RELATED ARTICLES

Zika Vaccine Shows Promise For Treating Deadly Brain Cancer

News

A Zika vaccine candidate has shown promise as a treatment for the deadliest type of brain cancer.

READ MORE

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

CRISPR Screen Identifies Gene That Helps Cells Resist West Nile, Zika Viruses

News

CRISPR used to identify a gene which helps cells resist a nasty class of pathogens.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE